BMW's Western Sales Surge Cannot Lift Shares From Year-Low Brink as China Crisis Deepens

Despite surging US and European deliveries, BMW shares trade near 2026 low after 20% China sales drop. Analysts hold buy ratings citing strong EV demand, but margin outlook slashed.

The gulf between BMW's operational prowess in the West and its stock market misery has rarely been wider. While the Munich-based automaker is selling more cars in the United States and Europe, its shares are trading just a whisker above the year's nadir, hammered by a deepening slump in China that shows no sign of easing.

US deliveries jumped 13% in the second quarter to more than 102,000 vehicles, with the X-series now accounting for over half of those sales. In Germany, June volumes rose nearly 19%. Across the Atlantic, Europe posted a 5.4% first-half gain to 496,651 units. Yet these strong performances were completely eclipsed by a 20.4% collapse in China, where deliveries sank to 261,773 vehicles in the first six months. Total global sales for the half came in at roughly 1.15 million, down 4.2% from a year earlier.

The stock closed Friday at €58.28, virtually flat on the day but down 3.92% on the week and 13.84% over the past month. Since January, BMW shares have lost 39.24% of their value. At that level, the equity is only 2.14% above its 2026 low of €57.06, touched on June 30, and a staggering 40.6% below the December 2025 record of €97.90.

Technical indicators paint a bleak picture. The 50-day moving average sits at €69.12 and the 200-day at €82.03, both far above the current price, leaving the stock 29% adrift of its long-term trend. The relative strength index of 31.1 signals oversold territory, historically a potential precursor to a bounce, but the annualized volatility of 31.44% suggests further turbulence ahead.

Analysts remain surprisingly constructive. LBBW raised its target to €85.00, citing the strong US market position. DZ Bank trimmed its fair value to €75.00 but maintains a buy recommendation, noting the price-to-earnings ratio has fallen to around seven times. JPMorgan reiterated its overweight rating with an €82 target, pointing to an order backlog for the new iX3 from the "Neue Klasse" that is approaching 100,000 vehicles — a sign of healthy EV demand in Europe despite the broader headwinds.

Behind the scenes, BMW completed a structural overhaul of its share capital, converting roughly 55 million preferred shares into common stock. The move aims to improve liquidity and attract international institutional investors, but it has done little to arrest the price slide so far.

The immediate catalyst is Tuesday's pre-close call on July 10, followed by the full half-year report on July 30. Investors will demand clarity on pricing strategy in China and progress on the ongoing cost-cutting programme. BMW already slashed its full-year margin guidance for the automotive division to between 1% and 3%, down from the original 4% to 6%, citing the China crisis and fallout from the Middle East conflict. The $1.7 billion investment at the Spartanburg plant in South Carolina, where the new X5 was unveiled, underscores the company's long-term commitment to its US operations, but it does little to dispel the near-term gloom.

Until the half-year numbers provide concrete answers on how BMW plans to navigate the Chinese downturn, the disconnect between its robust Western sales and its battered stock price looks set to persist.